Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Day

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|June 15, 2022
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and AsiaJulia C Cutts, Katherine O'Flaherty, Sophie G Zaloumis, et al.
BMC Medical Research Methodology|September 4, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialKamala Thriemer, Robert James Commons, Megha Rajasekhar, et al.
Nature Communications|May 20, 2025
Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong SubregionVaranya Wasakul, Tess D Verschuuren, Nguyen Thuy-Nhien, et al.
Plos Neglected Tropical Diseases|September 6, 2023
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiencyWalter R J Taylor, Niamh Meagher, Benedikt Ley, et al.
Frontiers in Cellular and Infection Microbiology|April 25, 2022
Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National StudyKatherine O'Flaherty, Jo-Anne Chan, Julia C Cutts, et al.
Nature Genetics|February 27, 2007
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisChiea C Khor, Stephen J Chapman, Fredrik O Vannberg, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Nature Communications|August 5, 2025
Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineagesMariana Kleinecke, Edwin Sutanto, Angela Rumaseb, et al.
The New England Journal of Medicine|May 21, 2010
CISH and susceptibility to infectious diseasesChiea C Khor, Fredrik O Vannberg, Stephen J Chapman, et al.
The Lancet. Infectious Diseases|July 27, 2019
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology studyWilliam L Hamilton, Roberto Amato, Rob W van der Pluijm, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|June 15, 2022
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and AsiaJulia C Cutts, Katherine O'Flaherty, Sophie G Zaloumis, et al.
BMC Medical Research Methodology|September 4, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialKamala Thriemer, Robert James Commons, Megha Rajasekhar, et al.
Nature Communications|May 20, 2025
Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong SubregionVaranya Wasakul, Tess D Verschuuren, Nguyen Thuy-Nhien, et al.
Plos Neglected Tropical Diseases|September 6, 2023
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiencyWalter R J Taylor, Niamh Meagher, Benedikt Ley, et al.
Frontiers in Cellular and Infection Microbiology|April 25, 2022
Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National StudyKatherine O'Flaherty, Jo-Anne Chan, Julia C Cutts, et al.
Nature Genetics|February 27, 2007
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisChiea C Khor, Stephen J Chapman, Fredrik O Vannberg, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Nature Communications|August 5, 2025
Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineagesMariana Kleinecke, Edwin Sutanto, Angela Rumaseb, et al.
The New England Journal of Medicine|May 21, 2010
CISH and susceptibility to infectious diseasesChiea C Khor, Fredrik O Vannberg, Stephen J Chapman, et al.
The Lancet. Infectious Diseases|July 27, 2019
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology studyWilliam L Hamilton, Roberto Amato, Rob W van der Pluijm, et al.
Pageof 11